Scilex Holding Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St

April 02, 2025

Scilex Holding (NASDAQ:SCLX) Full Year 2024 Results

Key Financial Results

Revenue: US$56.6m (up 21% from FY 2023).
Net loss: US$72.8m (loss narrowed by 56% from FY 2023).
US$0.56 loss per share (improved from US$1.28 loss in FY 2023).

We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

earnings-and-revenue-growth — NasdaqCM:SCLX Earnings and Revenue Growth April 2nd 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Scilex Holding EPS Beats Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 12%.

Looking ahead, revenue is forecast to grow 46% p.a. on average during the next 3 years, compared to a 8.4% growth forecast for the Pharmaceuticals industry in the US.

Performance of the American Pharmaceuticals industry.

The company's shares are down 4.7% from a week ago.

Risk Analysis

Don't forget that there may still be risks. For instance, we've identified 4 warning signs for Scilex Holding (2 are a bit unpleasant) you should be aware of.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.